In the ESPRIT trial [27], 11,255 patients with hypertension aged 50 years or older with a high cardiovascular risk were randomized to the intensive treatment group targeting a systolic blood pressure less than 120 mmHg or the standard treatment group targeting less than 140 mmHg
These results suggest that Exendin-4 can increase the number of glutamatergic neurons in the BLA brain region and is associated with a decrease in c-Fos expression following the cessation of Her + Ex-4 treatment
Contrave is generally indicated for adults with obesity or those who are overweight and have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Wash and glove your hands
Each receptor limb contributes a distinct downstream effect in preclinical models, and their concurrent activation is hypothesised to produce additive or synergistic metabolic signalling
doi: 10.1186/s10194-020-01111-8 77
